Schaeffer's Top Stock Picks for '25

Stocks On the Move: Celldex Therapeutics, Inc., Coupons.com Inc, and Nu Skin Enterprises, Inc.

CLDX, COUP, and NUS are moving sharply in Wednesday's trading

Nov 5, 2014 at 11:09 AM
facebook X logo linkedin


Around midday, three of the top market movers are biopharmaceutical name Celldex Therapeutics, Inc. (NASDAQ:CLDX), digital promotion platform Coupons.com Inc (NYSE:COUP), and anti-aging products marketer Nu Skin Enterprises, Inc. (NYSE:NUS). Here's a quick roundup of how CLDX, COUP, and NUS are performing on the charts so far.

  • CLDX has tumbled 11.5% this morning, despite a slimmer-than-expected third-quarter loss and revenue beat. At last check, the shares are perched at $14.67, bringing their year-to-date loss beyond 39%. In options land, traders have been buying to open puts over calls at a near-extreme rate in recent weeks. Specifically, during the past 10 days, Celldex Therapeutics, Inc. has racked up a put/call volume ratio of 1.24 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). Not only does this number reveal that long puts outstrip long calls, it also ranks just 1 percentage point from a 12-month high.

  • COUP has tacked on 24.5% to trade at $15.49, after exceeding the Street's expectations in the earnings confessional. In fact, since hitting a record low of $11.61 in late August, the Wall Street rookie has rallied more than 33%. Nevertheless, just one brokerage firm is currently following Coupons.com Inc., and 7.4% of the equity's float is sold short, representing more than six sessions' worth of pent-up buying demand, at average daily trading levels. Should the shares maintain their recent positive momentum, a round of bullish initiations and/or a short-covering rally could be in the cards.

  • Finally, NUS plunged to an annual low of $39.46 earlier, and was last seen 15% south of breakeven at $42.84. Impacting the security today was a reduced current-quarter forecast, which overshadowed a third-quarter earnings and revenue beat. Year-to-date, Nu Skin Enterprises, Inc. is now sitting on a brow-raising deficit of 69%. Elsewhere, at the ISE, CBOE, and PHLX, the stock's 10-day put/call volume ratio of 1.00 ranks higher than 70% of all other readings from the past year -- suggesting options traders have been buying to open puts over calls at a faster-than-usual clip lately.
 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?

 

 

(function(doc, script) { var js, fjs = doc.getElementsByTagName(script)[0], frag = doc.createDocumentFragment(), add = function(url, id) { if (doc.getElementById(id)) {return;} js = doc.createElement(script); js.src = url; id && (js.id = id); frag.appendChild( js ); }; // Google+ button //add('https://apis.google.com/js/platform.js', async="defer"); // Facebook SDK add('//connect.facebook.net/en_US/all.js#xfbml=1&appId=772755279557744', 'facebook-jssdk'); // Twitter SDK //add('//platform.twitter.com/widgets.js', charset='utf-8'); fjs.parentNode.insertBefore(frag, fjs); }(document, 'script'));